Skip to main content
Clinical Trials/NCT04301102
NCT04301102
Completed
N/A

Intraoperative Hemodynamic Optimization Using the Hypotension Prediction Index and Its Impact of Tissular Perfusion

Juan Victor Lorente5 sites in 1 country80 target enrollmentNovember 1, 2020

Overview

Phase
N/A
Intervention
Not specified
Conditions
Intraoperative Hypotension
Sponsor
Juan Victor Lorente
Enrollment
80
Locations
5
Primary Endpoint
TWA-MAP< 65 mmHg
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The aim of the study is to determine whether a goal-directed algorithm based on the prevention of arterial hypotension using the Hypotension Prediction Index reduces the duration and severity of intraoperative hypotension when compared with the recommended standard therapy and if this intraoperative strategy affects tissue oxygenation and organ perfusion.

Detailed Description

Background: Intraoperative arterial hypotension is associated with poor postoperative outcomes. The Hypotension Prediction Index developed from machine learning, predicts the occurrence of arterial hypotension from the analysis of the arterial pressure waveform. The use of this index can reduce the duration and severity of intraoperative hypotension in adults undergoing noncardiac surgery. Methods: We will conduct a multicenter, randomized, controlled trial (N=80) in high-risk surgical patients scheduled for elective major abdominal surgery. All participants will be randomly assigned to a control or intervention group. Hemodynamic management in the control group will be based on standard hemodynamic parameters. Hemodynamic management of patients in the intervention group will be based on functional hemodynamic parameters provided by Hemosphere platform (Edwards Lifesciences Ltd), including dynamic arterial elastance, dP/dtmax and the Hypotension Prediction Index. Tissue oxygen saturation will be non-invasively and continuously recorded by using near-infrared spectroscopy technology. Biomarkers of acute kidney stress (cTIMP2 and IGFBP7) will be obtained before and after surgery. The primary outcome will be intraoperative time-weighted average with a mean arterial pressure \< 65mmHg. Discussion: The aim of the study is to determine whether a goal-directed algorithm based on the prevention of arterial hypotension using the Hypotension Prediction Index reduces the duration and severity of intraoperative hypotension when compared with the recommended standard therapy and if this intraoperative strategy affects tissue oxygenation and organ perfusion.

Registry
clinicaltrials.gov
Start Date
November 1, 2020
End Date
June 1, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Juan Victor Lorente
Responsible Party
Sponsor Investigator
Principal Investigator

Juan Victor Lorente

Anesthesiologist

Andalusian Network for Design and Translation of Advanced Therapies

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

TWA-MAP< 65 mmHg

Time Frame: Intraoperatively

Area between 65 mmHg threshold and the curve of the MAP measurements divided by the total continuous reading time mmHg for a minimum duration of 1 minute (3 consecutive records from one minute to more between two consecutive falls).

Number of intraoperative hypotension episodes

Time Frame: Intraoperatively

defined as an event of MAP \< 65 mmHg of at least 1-minute duration

Total time of hypotension per case

Time Frame: Intraoperatively

Intraoperative Total time of hypotension (MAP \< 65 mmHg)

Secondary Outcomes

  • StO2(Intraoperatively)
  • Postoperative complications(Postoperatively)
  • Total fluid therapy during surgery(Intraoperatively)
  • Acute kidney stress biomarkers(NC1: after anestesic induction // NC2: First 4 hours after the patient is admitted to the UCI/REA // NC3: 12 hours after NC2.)
  • Accumulated dose during the intraoperative period of vasoactive(Intraoperatively)
  • Need and accumulated dose of drugs not included in previous groups(Intraoperatively)
  • Transfusion of total blood products during surgery(Intraoperatively)
  • Length of hospital stay(At 30 days)
  • Mortality(At 30 days)
  • Accumulated dose of Fentanyl, remifentanyl and/or morphine.(Intraoperatively)
  • Accumulated dose during the intraoperative period of ionotopic drug(Intraoperatively)

Study Sites (5)

Loading locations...

Similar Trials